US Stock MarketDetailed Quotes

CMND Clearmind Medicine

Watchlist
  • 1.1960
  • -0.0040-0.33%
Trading Apr 26 13:48 ET
3.90MMarket Cap-64P/E (TTM)

Clearmind Medicine Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Oct 31, 2023
(Q4)Oct 31, 2023
(Q3)Jul 31, 2023
(Q2)Apr 30, 2023
(Q1)Jan 31, 2023
(FY)Oct 31, 2022
(Q4)Oct 31, 2022
(Q3)Jul 31, 2022
(Q2)Apr 30, 2022
(Q1)Jan 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
0.83%6.3M
48.47%1.71M
-18.36%1.1M
-25.43%1.66M
18.59%2.47M
132.10%6.25M
-12.88%1.15M
24.77%1.35M
1,076.07%2.22M
2,013.74%2.08M
Selling and administrative expenses
52.21%4.72M
751.01%1.3M
-18.20%838.93K
26.28%1.34M
1.17%1.68M
39.87%3.1M
-122.05%-199.55K
0.01%1.03M
461.32%1.06M
1,583.51%1.66M
-General and administrative expense
52.21%4.72M
751.01%1.3M
-18.20%838.93K
26.28%1.34M
1.17%1.68M
39.87%3.1M
-122.05%-199.55K
0.01%1.03M
461.32%1.06M
1,583.51%1.66M
Research and development costs
-49.88%1.54M
-70.79%375.07K
-18.86%263.95K
-72.64%317.57K
86.79%792.46K
550.48%3.08M
208.38%1.28M
468.15%325.32K
--1.16M
--424.26K
Depreciation amortization depletion
-45.34%37.3K
----
----
----
----
3,518.08%68.24K
----
----
----
----
-Depreciation and amortization
-45.34%37.3K
----
----
----
----
3,518.08%68.24K
----
----
----
----
Operating profit
-0.83%-6.3M
-48.47%-1.71M
18.36%-1.1M
25.43%-1.66M
-18.59%-2.47M
-132.10%-6.25M
12.88%-1.15M
-24.77%-1.35M
-1,076.07%-2.22M
-2,013.74%-2.08M
Net non-operating interest income expense
510.45%59.17K
224.06%17.89K
255.54%17.31K
5.97K
36.88K
-14.42K
-14.42K
-11.13K
0
0
Non-operating interest income
----
----
----
--5.97K
--36.88K
----
----
----
--0
--0
Total other finance cost
-510.45%-59.17K
---17.89K
-255.54%-17.31K
----
----
--14.42K
----
--11.13K
----
----
Other net income (expense)
-293.75%-2.36M
-542.15%-2.36M
516.29%503.75K
-296.65%-417.06K
-205.93%-19.78K
-1,778.78%-599.16K
-368.27K
-121.01K
-105.15K
-6.46K
Gain on sale of security
-293.75%-2.36M
-542.15%-2.36M
516.29%503.75K
-296.65%-417.06K
-205.93%-19.78K
-2,339.18%-599.16K
---368.27K
---121.01K
---105.15K
---6.46K
Special income (charges)
--0
----
----
----
----
--0
----
----
----
----
-Less:Impairment of capital assets
--0
----
----
----
----
--0
----
----
----
----
Income before tax
-25.32%-8.6M
-164.32%-4.06M
60.77%-581.82K
11.12%-2.07M
-17.41%-2.45M
-151.90%-6.87M
-13.30%-1.54M
-36.97%-1.48M
-1,131.75%-2.33M
-2,020.29%-2.09M
Income tax
-41.82%17.37K
-61.98%11.35K
-6.63K
9.27K
4.56K
29.86K
29.86K
0
0
0
Net income
-25.03%-8.62M
-160.00%-4.07M
61.21%-575.19K
10.72%-2.08M
-17.63%-2.46M
-153.00%-6.89M
-15.51%-1.57M
-36.97%-1.48M
-1,131.75%-2.33M
-2,020.29%-2.09M
Net income continuous Operations
-25.03%-8.62M
-160.00%-4.07M
61.21%-575.19K
10.72%-2.08M
-17.63%-2.46M
-153.00%-6.89M
-15.51%-1.57M
-36.97%-1.48M
-1,131.75%-2.33M
-2,020.29%-2.09M
Minority interest income
Net income attributable to the parent company
-25.03%-8.62M
-160.00%-4.07M
61.21%-575.19K
10.72%-2.08M
-17.63%-2.46M
-153.00%-6.89M
-15.51%-1.57M
-36.97%-1.48M
-1,131.75%-2.33M
-2,020.29%-2.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-25.03%-8.62M
-160.00%-4.07M
61.21%-575.19K
10.72%-2.08M
-17.63%-2.46M
-153.00%-6.89M
-15.51%-1.57M
-36.97%-1.48M
-1,131.75%-2.33M
-2,020.29%-2.09M
Basic earnings per share
73.24%-42.58
80.47%-6.7011
92.86%-2.4
69.10%-16.5
35.93%-32.1
-80.48%-159.11
-0.44%-34.31
-24.44%-33.6
-493.33%-53.4
-456.67%-50.1
Diluted earnings per share
73.24%-42.58
80.47%-6.7011
92.86%-2.4
69.10%-16.5
35.93%-32.1
-80.48%-159.11
-0.44%-34.31
-24.44%-33.6
-493.33%-53.4
-456.67%-50.1
Dividend per share
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Oct 31, 2023(Q4)Oct 31, 2023(Q3)Jul 31, 2023(Q2)Apr 30, 2023(Q1)Jan 31, 2023(FY)Oct 31, 2022(Q4)Oct 31, 2022(Q3)Jul 31, 2022(Q2)Apr 30, 2022(Q1)Jan 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 0.83%6.3M48.47%1.71M-18.36%1.1M-25.43%1.66M18.59%2.47M132.10%6.25M-12.88%1.15M24.77%1.35M1,076.07%2.22M2,013.74%2.08M
Selling and administrative expenses 52.21%4.72M751.01%1.3M-18.20%838.93K26.28%1.34M1.17%1.68M39.87%3.1M-122.05%-199.55K0.01%1.03M461.32%1.06M1,583.51%1.66M
-General and administrative expense 52.21%4.72M751.01%1.3M-18.20%838.93K26.28%1.34M1.17%1.68M39.87%3.1M-122.05%-199.55K0.01%1.03M461.32%1.06M1,583.51%1.66M
Research and development costs -49.88%1.54M-70.79%375.07K-18.86%263.95K-72.64%317.57K86.79%792.46K550.48%3.08M208.38%1.28M468.15%325.32K--1.16M--424.26K
Depreciation amortization depletion -45.34%37.3K----------------3,518.08%68.24K----------------
-Depreciation and amortization -45.34%37.3K----------------3,518.08%68.24K----------------
Operating profit -0.83%-6.3M-48.47%-1.71M18.36%-1.1M25.43%-1.66M-18.59%-2.47M-132.10%-6.25M12.88%-1.15M-24.77%-1.35M-1,076.07%-2.22M-2,013.74%-2.08M
Net non-operating interest income expense 510.45%59.17K224.06%17.89K255.54%17.31K5.97K36.88K-14.42K-14.42K-11.13K00
Non-operating interest income --------------5.97K--36.88K--------------0--0
Total other finance cost -510.45%-59.17K---17.89K-255.54%-17.31K----------14.42K------11.13K--------
Other net income (expense) -293.75%-2.36M-542.15%-2.36M516.29%503.75K-296.65%-417.06K-205.93%-19.78K-1,778.78%-599.16K-368.27K-121.01K-105.15K-6.46K
Gain on sale of security -293.75%-2.36M-542.15%-2.36M516.29%503.75K-296.65%-417.06K-205.93%-19.78K-2,339.18%-599.16K---368.27K---121.01K---105.15K---6.46K
Special income (charges) --0------------------0----------------
-Less:Impairment of capital assets --0------------------0----------------
Income before tax -25.32%-8.6M-164.32%-4.06M60.77%-581.82K11.12%-2.07M-17.41%-2.45M-151.90%-6.87M-13.30%-1.54M-36.97%-1.48M-1,131.75%-2.33M-2,020.29%-2.09M
Income tax -41.82%17.37K-61.98%11.35K-6.63K9.27K4.56K29.86K29.86K000
Net income -25.03%-8.62M-160.00%-4.07M61.21%-575.19K10.72%-2.08M-17.63%-2.46M-153.00%-6.89M-15.51%-1.57M-36.97%-1.48M-1,131.75%-2.33M-2,020.29%-2.09M
Net income continuous Operations -25.03%-8.62M-160.00%-4.07M61.21%-575.19K10.72%-2.08M-17.63%-2.46M-153.00%-6.89M-15.51%-1.57M-36.97%-1.48M-1,131.75%-2.33M-2,020.29%-2.09M
Minority interest income
Net income attributable to the parent company -25.03%-8.62M-160.00%-4.07M61.21%-575.19K10.72%-2.08M-17.63%-2.46M-153.00%-6.89M-15.51%-1.57M-36.97%-1.48M-1,131.75%-2.33M-2,020.29%-2.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -25.03%-8.62M-160.00%-4.07M61.21%-575.19K10.72%-2.08M-17.63%-2.46M-153.00%-6.89M-15.51%-1.57M-36.97%-1.48M-1,131.75%-2.33M-2,020.29%-2.09M
Basic earnings per share 73.24%-42.5880.47%-6.701192.86%-2.469.10%-16.535.93%-32.1-80.48%-159.11-0.44%-34.31-24.44%-33.6-493.33%-53.4-456.67%-50.1
Diluted earnings per share 73.24%-42.5880.47%-6.701192.86%-2.469.10%-16.535.93%-32.1-80.48%-159.11-0.44%-34.31-24.44%-33.6-493.33%-53.4-456.67%-50.1
Dividend per share
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg